Heidelberg Materials AG : A good level to buy
Entry price | Target | Stop-loss | Potential |
---|
€73 |
€79.88 |
€68.14 |
+9.42% |
---|
The recent downward movement has sent HeidelbergCement AG shares back to attractive levels situated around 70.48 EUR. This zone could put an end to the downward movement and offers a good timing for new long positions.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● In a short-term perspective, the company has interesting fundamentals.
●
Strengths● Its low valuation, with P/E ratio at 9.61 and 8.96 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
● As regards fundamentals, the enterprise value to sales ratio is at 1.11 for the current period. Therefore, the company is undervalued.
●
●
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
●
●
Weaknesses● According to forecast, a sluggish sales growth is expected for the next fiscal years.
●
●
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.